Bianca Nogrady
Bianca Nogrady is an award-winning freelance science journalist and author who reports medical news for Medscape, with a focus on how clinical evidence and health policy decisions affect everyday medical practice.
Health system, insurers, and medical workforce
Nogrady’s Medscape coverage tracks the structural shifts in the health system, especially the relationships between doctors, insurers, and government funding. She reports on private health insurers buying up general practice clinics and examines how vertical integration can influence patient choice and referral patterns, drawing out clinicians’ concerns about conflicts of interest and care quality. She follows that thread into contractual arrangements, detailing how doctors are pushing back against restrictive insurer contracts and highlighting calls for greater regulation and transparency in the private health insurance sector.
Her health policy reporting extends to government spending and workforce planning, such as reactions from medical groups to federal budgets that boost hospital funding while offering limited support for general practice. She covers the growing number of medical students choosing to train as rural generalists, explaining how formal recognition of rural generalist medicine as a specialty is reshaping career pathways and service provision in remote communities. Across these stories, she connects system-level changes to frontline impacts, showing how funding models, ownership structures, and specialty recognition translate into choices for doctors and patients.
Preventive care and screening programs are part of this systems lens: she reports on the introduction and strong uptake of new lung cancer screening initiatives, framing them within broader debates about access, early diagnosis, and the design of population-level interventions. Her health system work consistently combines policy detail with clinical context.
Osteoarthritis, musculoskeletal care, and exercise interventions
A substantial strand of Nogrady’s reporting focuses on osteoarthritis and musculoskeletal medicine, where she closely interrogates the evidence behind common therapies. She has covered trials of online, unsupervised tai chi programs for knee osteoarthritis, explaining how a 12-week video-based intervention translated into clinically meaningful improvements in pain and function and quantifying effect sizes and numbers needed to treat. She reports from major osteoarthritis conferences, such as the World Congress on Osteoarthritis, where she has written about randomized controlled trials comparing sham physical therapy with standard physical therapy for meniscal tear plus osteoarthritis, emphasising that both produced similar pain reductions and only modest benefits over home-based exercise.
Her work on osteoarthritis also includes overviews of systematic reviews and randomized trials that question the magnitude and durability of exercise benefits, highlighting when evidence is of low or moderate certainty and clarifying the difference between statistically significant and clinically important effects. She draws on long-term follow-up data from studies such as the FIDELITY trial of arthroscopic partial meniscectomy to show how surgical interventions compare with conservative care over a decade. In this sub-beat, Nogrady’s reporting is distinguished by its close attention to trial design, outcome measures, and certainty of evidence, and by her willingness to foreground inconclusive or nuanced findings rather than simple pro–con narratives.
Rheumatology, vasculitis, and infection risk
Nogrady also covers complex immunologic conditions and the intersection of immunosuppressive therapy with vaccination and infection risk. She reports on studies showing that rituximab treatment for ANCA-associated vasculitis reduces responses to pneumococcal vaccination, explaining the mechanisms, the measured impact on immunogenicity, and the implications for timing and choice of vaccines in these patients. In companion coverage, she examines which factors raise infection risk in ANCA vasculitis, detailing how clinical characteristics, treatment regimens, and comorbidities influence outcomes.
Her rheumatology work extends beyond vasculitis to lupus clinical trials, where she has written about how patient selection is key to lowering placebo response rates, drawing out practical lessons for future trial design and endpoint choice in systemic autoimmune disease. Across these stories, she focuses on how clinicians can balance disease control with protection against infection, using data-driven reporting to clarify risks and trade-offs for audiences managing immunosuppressed patients.
Emergency care, digital tools, and the science community
In emergency medicine and cardiology, Nogrady reports on interventions that bridge clinical practice and technology, such as smartphone-activated systems that alert trained bystanders to nearby out-of-hospital cardiac arrests. She explains how volunteer responders arriving before emergency medical services significantly increase rates of bystander CPR and defibrillation, and how that translates into higher odds of survival to discharge, making clear where the app’s impact is greatest and where it is limited. Her reporting in this area gives clinicians and policymakers concrete data on the value of digital tools in prehospital care.
Beyond strictly clinical topics, Nogrady writes about the environment in which health and science professionals work, including features on the targeting and harassment of scientists and public health officials. In her Nature coverage, she documents the emotional and professional toll of abuse directed at experts during public health crises, situating individual experiences within broader debates about trust in science and the protection of those who communicate evidence to the public. This combination of high-detail clinical reporting and attention to the lived realities of the science community marks her out as a journalist who covers both what the data show and what it means for the people who generate and apply that knowledge.
4 more health journalists.
Abida Tasnim
Abida Tasnim is a health writer for The Daily Star who focuses on clear, practical guidance that helps readers recognise risks early and act before everyday illnesses turn into wider public health problems. She reports on infectious disease prevention, using measles coverage to show how outbreaks start with individual decisions and behaviours, not just hospital statistics. Her work explains what happens during an outbreak and then anchors the story in simple steps people can take, such as avoiding crowded places when symptoms appear, practising good hygiene, and seeking medical advice early. She writes direct, action‑oriented health explainers that turn clinical questions about contagion and disease burden into everyday choices. Across her beat, she stresses early recognition, timely care, and prevention as the foundations of healthier communities.
Adrián Carballo Casla
Adrián Carballo Casla stands out for turning complex cohort data on ageing into clear, food‑level advice on what older adults should eat to protect brain health and slow chronic disease. He is a researcher in nutritional epidemiology focused on ageing and chronic disease prevention and a postdoctoral researcher in geriatric epidemiology at Karolinska Institutet, writing health explainers for The Conversation. He reports on how diet quality, especially Mediterranean and Mind‑style patterns, shapes dementia risk, grey matter loss and neurocognitive ageing, and how healthy versus pro‑inflammatory diets alter multimorbidity trajectories. His articles translate findings on flavonoids, polyphenols, folate, omega‑3 fats and dietary nitrates into specific food choices and small, practical changes. Much of his coverage is anchored in his own studies on multimorbidity, high‑risk older adults and tailored dietary recommendations, often syndicated to other outlets.
Ahmed Elbediwy
Ahmed Elbediwy brings a lab-based understanding of cancer biology and clinical biochemistry to public-facing health reporting, linking drug mechanisms and molecular pathways to everyday choices about medicines and products. He writes for The Conversation on weight-loss injections, cancer overdiagnosis and anti-ageing supplements, focusing on obesity medicine, cancer signalling, screening trade-offs, skincare and supplement science. His pieces on GLP-1 drugs such as Ozempic, Wegovy and Mounjaro explain why some people do not respond, how gut hormones and appetite signals work, and where psychological support and nutrition fit alongside prescriptions. He co-authors explainers on cancer risk and overdiagnosis and on whether supplements can reverse ageing, separating established knowledge from emerging research. An award-winning senior lecturer at Kingston University, he favours clear, structured explainers, careful definition of key terms and evidence-based appraisal over hype.
Amanda Sheppeard
Amanda Sheppeard is a managing editor and health journalist known for long, detailed explainers that connect complex clinical research, disability policy and political narratives with the daily realities of doctors and patients. She works at The Medical Republic across editorial leadership and commercial content while reporting widely on medicine for its specialist titles. Her real beat spans autism, disability policy, autoimmune disease, infectious threats and system pressures in primary care and hospitals. She covers subjects such as autism diagnosis and the NDIS, rheumatology’s clinical shifts, weight-loss agents in rheumatoid arthritis, infection control, antimicrobial resistance and new modalities like CAR T-cell therapy and microneedles. She reports by doing the synthesis inside the story, linking trial design, molecular targets, funding rules and policy changes to concrete decisions and workflows in clinics and hospitals.